Prostate cancer treatment

NEW YORK, June 28 (Praxis Press) Many treatment options are available for men with prostate cancer but therapeutic recommendations may vary depending on the type of specialist they consult. Fowler and colleagues attempted to define and contrast the distribution of prostate cancer management recommendations given by urologists and radiation oncologists (see paper). To perform the study they mailed a survey to a random sample of physicians in the United States, who were listed as urologists (respo


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, June 28 (Praxis Press) Many treatment options are available for men with prostate cancer but therapeutic recommendations may vary depending on the type of specialist they consult. Fowler and colleagues attempted to define and contrast the distribution of prostate cancer management recommendations given by urologists and radiation oncologists (see paper). To perform the study they mailed a survey to a random sample of physicians in the United States, who were listed as urologists (response rate 64%, n=504) and radiation oncologists (response rate 76%, n=559) in the American Medical Association Registry of Physicians and practicing at least 20 hours per week. They found that each of the specialists overwhelmingly recommended the therapy that they themselves deliver. Urologists and radiation oncologists agree on a variety of issues regarding detection and treatment of prostate cancer but are swayed to a type of treatment based on their specialty.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours